| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,325 | 24,167 | 20,031 | 33,450 | | Cost of Revenue | 14,151 | 24,922 | 16,875 | 21,194 | | | Gross Profit | 7,174 | (755) | 3,156 | 12,256 | | | Operating Expenses | | Research Development | 3,647 | 6,296 | 7,008 | 5,815 | | Selling General and Administrative | 6,555 | 13,079 | 15,959 | 12,384 | | Non Recurring | 221 |
-
|
-
|
-
| | Others |
-
| (1,014) | 15 | 617 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,249) | (19,116) | (19,826) | (6,560) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 111 | 425 | (80) | 993 | | Earnings Before Interest And Taxes | (3,138) | (18,691) | (19,906) | (5,567) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (3,138) | (18,691) | (19,906) | (5,567) | | Income Tax Expense | 682 | 28,690 | (4,908) | (1,898) | | Minority Interest | (132) | (44) | (103) | (372) | | | | Net Income From Continuing Ops | (3,820) | (47,425) | (15,101) | (4,041) | | | Non-recurring Events | | Discontinued Operations | (1,835) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,787) | (47,425) | (15,101) | (4,041) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,787) | ($47,425) | ($15,101) | ($4,041) |
|
0.02% Nasdaq 0.00%
Income Statement
